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ABSTRACT 
Purpose: The purpose of the study was to investigate the diagnostic value of SPECT, PET and PET/CT in the 
diagnosis of coronary artery disease, based on a systematic review.  
Material and Methods: A search of PubMed/Medline and Sciencedirect databases in the English-language 
literature published over the last 24 years was performed. Only studies with at least 10 patients comparing SPECT, PET 
or combined PET/CT with invasive coronary angiography in the diagnosis of coronary artery disease (50% stenosis) 
were included for analysis. Sensitivities and specificities estimates pooled across studies were analysed using a Chi-
square test. 
Results: Twenty-five studies met the selection criteria and were included for the analysis. Ten studies were 
performed with SPECT alone; while another six studies were performed with PET alone. Five studies were carried out 
with both PET and SPECT modalities, and the remaining four studies were investigated with integrated PET-CT. The 
mean value of sensitivity, specificity and accuracy of these imaging modalities for the diagnosis of coronary artery 
disease was 82% (95%CI: 76 to 88), 76% (95%CI: 70 to 82) and 83% (95%CI: 77 to 89) for SPECT; 91% (95%CI: 85 
to 97), 89% (95%CI: 83 to 95) and 89% (95%CI: 83 to 95) for PET; and 85% (95%CI: 79 to 90), 83% (95%CI: 77 to 89) 
and 88% (95%CI: 82 to 94) for PET/CT, respectively. The diagnostic accuracy of these imaging modalities was 
dependent on the radiotracers used in these studies, with ammonia resulting in the highest diagnostic value. 
Conclusion: Our review shows that PET has high diagnostic value for diagnosing coronary artery disease, and this 
indicates that it is a valuable technique for both detection and prediction of coronary artery disease. © 2011 Biomedical 
Imaging and Intervention Journal. All rights reserved. 
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Figure 1 Flow chart shows the searching strategy of eligible 
references 
 
INTRODUCTION 
A Coronary artery disease (CAD) remains the 
leading cause of mortality and morbidity in Western 
countries [1]. Invasive coronary angiography is currently 
the gold standard for diagnosis and treatment of CAD; 
however, it is an invasive procedure associated with risks 
and complications [2]. Moreover, it is reported that 
around 20% to 40% of all diagnostic invasive coronary 
angiography procedures were performed for diagnostic 
purposes without any interventional procedures being 
applied [3-5]. Thus, investigation of less invasive 
imaging modalities is important for reducing or avoiding 
the use of invasive coronary angiography examinations 
[6]. 
Currently, multislice computed tomography (CT) 
angiography is widely used in clinical practice for the 
diagnosis of CAD, and its diagnostic accuracy has been 
significantly enhanced with the recent development of 
64-, 256- and 320-slice scanners [7-10]. Studies have 
shown that multislice CT angiography can be used as a 
reliable alternative to invasive coronary angiography in 
selected patients, due to its high sensitivity and 
specificity [7-10].  
Myocardial perfusion imaging with SPECT is a 
widely established method for non-invasive evaluation of 
coronary artery stenosis [11]. However, the most 
important applications of SPECT are in the diagnosis of 
CAD, prediction of disease prognosis, selection of 
patients for revascularisation and assessment of acute 
coronary syndromes. Moreover, SPECT holds special 
value in some particular patient subgroups [12, 13]. 
Generally speaking, the sensitivity of stress SPECT for 
detecting angiographically-defined CAD is consistently 
above 70%, but in the better-designed studies, it is within 
the range of 85-90% [14, 15]. 
Positron emission tomography (PET) has 
contributed significantly to advancing our understanding 
of heart physiology and pathophysiology for more than 
25 years. The diagnostic accuracy of myocardial 
perfusion by PET in the assessment of CAD has been 
reported to be superior to SPECT [16-17]. PET with rest-
stress myocardial perfusion is regarded as an exact 
imaging modality for diagnosing and managing patients 
with CAD [17]. Moreover, the combined modality of 
PET/CT further increases the diagnostic accuracy in 
CAD [13-17]. 
Despite promising results reported in the literature 
[18, 19], the diagnostic value of SPECT and PET to 
detect CAD has not been well established. This is mainly 
due to the fact that the diagnostic accuracy reported by 
these studies is variable and the radiopharmaceuticals 
used in these studies are different. Thus, the purpose of 
our study was to investigate the diagnostic value of 
SPECT, PET and PET/CT when compared to invasive 
coronary angiography for detection of CAD, based on a 
systematic review of the current literature. 
MATERIALS AND METHODS 
A search of the English-language literature was 
performed using two main databases, PubMed/Medline 
and ScienceDirect. The search included articles 
published between 1985 and 2009 on the topics of 
SPECT, PET and PET/CT in CAD. The research was 
limited to peer-reviewed articles on human subjects and 
studies published in the English language. The keywords 
used for the search were “Positron Emission 
Tomography”, “Single Photon Emission Computed 
Tomography”, “integrated Positron Emission 
Tomography and Computed Tomography”, “Coronary 
Artery Disease”, “Myocardial perfusion”, “Nuclear 
Medicine Imaging in cardiac disease”. The reference lists 
for studies matching these criteria were also reviewed to 
identify additional articles which were not found through 
the initial search. The last search was performed in 
September 2010 to ensure inclusion of all recent 
publications in the analysis.  
Articles that met the following criteria were 
included for analysis: SPECT, PET, or PET/CT studies Al Moudi et al. Biomed Imaging Interv J 2011; 7(2):e9 
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Figure 2 Overall pooled mean diagnostic value of SPECT, PET 
and PET/CT for detection of coronary artery disease. 
 
were performed in patients who underwent myocardial 
perfusion imaging (MPI) rest/stress test while invasive 
coronary angiography was used as the standard of 
reference; at least ten patients were included in each 
study; diagnosis of CAD was based on >50% stenosis. 
The reason >50% stenosis was chosen was because it has 
become a routine clinical practice to consider coronary 
stenosis >50% as haemodynamically significant [20-22]. 
Also, the diagnostic value in terms of sensitivity and 
specificity was reported in the study. The exclusion 
criteria included: review articles or case study reports; 
animal or phantom studies; studies dealing with 
myocardial perfusion without addressing the diagnostic 
accuracy of coronary artery stenosis or occlusion, and 
studies including patients treated with coronary stents or 
bypass grafts. 
Two reviewers checked the references 
independently and the following information was 
extracted from each study: year of publication; number 
of participants in the study; prevalence of patients with 
suspected or confirmed CAD; mean age; percentage of 
male patients affected; type of radiotracer used in each 
study; rest and stress imaging protocols; diagnostic value 
of SPECT, PET and PET/CT in terms of sensitivity and 
specificity; and the accuracy of SPECT, PET and 
PET/CT for detection of CAD. The main findings were 
summarised in terms of the extent to which studies were 
reported to have shown the value of using SPECT, PET 
and PET-CT to diagnose CAD towards improving 
patient management and cost-effectiveness. 
All of the statistical analyses were undertaken using 
SPSS software version 17.0 (SPSS Inc., Chicago, ILL). 
Each of the study estimates for sensitivity and specificity 
were independently combined across studies using one 
sample test. Comparison was performed by Chi Square 
test using n-1 degree of freedom to test if there are any 
significant differences between different imaging 
modalities (SPECT vs PET, SEPCT vs PET/CT, PET vs 
PET/CT). Statistical hypotheses (2-tailed) were tested at 
the 5% level of significance. 
RESULTS 
Twenty-five studies (with 25 comparisons) met the 
selection criteria and were included in the analysis [20-
44]. Ten of these studies were performed with SPECT 
alone [20-25, 40-42, 44], while six of the studies were 
performed with PET alone [31-36]. Five studies were 
carried out with both PET and SPECT modalities [26-30] 
and the remaining four studies were investigated with 
integrated PET/CT [37-39, 43]. The total number of 
patients included in these studies was 4,114 with 53.5% 
of the patients suspected of CAD, 72.2 % being male and 
the mean age of patients being 48-years-old. Table 1 
summarises the number of patients, the radiotracers used 
in each study, and the reported sensitivity, specificity and 
accuracy with use of SPECT, PET and PET/CT imaging 
modalities, respectively.  
The degree of coronary artery stenosis was assessed 
based on the criterion of >50%, which was determined 
by invasive coronary angiography in all studies. Of these 
20 studies, 82Rubidium was the most commonly-used 
radiopharmaceutical which was utilised in 10 studies 
[27–29, 31-34, 37-39]; 99mTc-Sestamibi was used in 
seven studies [20-22, 24, 25, 27, 42]; 201Thallium was 
used in four studies [26, 27, 29, 30]; a combination of 
201Thallium and 99mTc-Sestamibi was used in one 
study [23]; 99mTc-Tetrofosmin was used in three studies 
[40, 41, 44]; and combinations of 13N Ammonia and 
82Rubidium were used in the remaining two studies [35, 
36].  
Analysis of diagnostic value of SPECT in CAD 
A total of 2,208 patients were included in 15 SPECT 
studies based on significant CAD which was determined 
by visual assessment of coronary angiography. Figure 2 
shows the mean sensitivity, specificity and accuracy of 
SPECT for diagnosis of CAD. As shown in the figure, 
the diagnostic value of SPECT was moderate when 
compared to invasive coronary angiography. 
Analysis of diagnostic value of PET in CAD 
1,376 patients were included in another 11 studies 
performed with PET tests based on significant CAD 
which was determined by visual assessment of coronary 
angiography. Figure 2 shows the mean sensitivity, 
specificity and accuracy of PET for diagnosis of CAD. 
As shown in the figure, PET imaging was found to have 
high diagnostic value in the detection of CAD. 
Analysis of diagnostic value of PET/CT in CAD 
518 patients were included in four studies performed 
with PET/CT studies based on significant CAD which 
was determined by visual assessment of coronary 
angiography. Again Figure 2 demonstrates that moderate 
sensitivity, specificity and accuracy of PET/CT were 
reached for diagnosis of CAD.  A
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Figure 3 Pooled diagnostic value of SPECT for detection of 
coronary artery disease based on individual coronary 
artery assessment. 
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Figure 4 Pooled diagnostic value of PET for detection of 
coronary artery disease based on individual coronary 
artery assessment. 
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Figure 5 Pooled diagnostic value of PET/CT for detection of 
coronary artery disease based on individual coronary 
artery assessment. 
 
 
Comparison of SPECT, PET and PET/CT  
There is a significant difference in sensitivity, 
specificity and accuracy between PET and SPECT, PET 
and PET/CT, SPECT and PET/CT for the diagnosis of 
CAD (p<0.05), with PET demonstrating the highest 
diagnostic value among these three imaging modalities 
as shown in Figure 2. 
Analysis of diagnostic value for assessment of individual 
coronary artery disease 
Table 2 demonstrates the diagnostic value of SPECT, 
PET and PET/CT in three studies with five comparisons 
based on analysis of three main coronary arteries.  
Figures 3 to 5 demonstrate the overall results of 
sensitivity, specificity and accuracy analysed with three 
different nuclear medicine modalities at left anterior 
descending (LAD), left circumflex (LCx) and right 
coronary artery (RCA). As shown in the figures, PET has 
the highest diagnostic value among the 3 imaging 
modalities for diagnosis of CAD. 
Analysis of effects of different Radiotracers on diagnostic 
value 
Since different types of radiotracers were used in 
these 20 studies, analyses of the diagnostic value of 
variable radiotracers for detection of CAD were 
investigated. Table 3 shows the radiotracers used in these 
studies and their corresponding diagnostic value. As 
demonstrated in the table, using ammonia as a 
radiotracer produced the highest diagnostic value for 
detection of CAD. 
Figure 6 shows the differences in sensitivity and 
specificity between both 201Thallium and 99mTc-
sestamibi for the diagnosis of CAD (p<0.05), and also 
significant differences in the specificity and accuracy 
between both 201Thallium and 99mTc-sestamibi and 
individual radiotracers for the diagnosis of CAD 
(p<0.05). 
Significant differences in sensitivity and accuracy 
was found between 13N ammonia, 82Rubidium and both 
13N ammonia with 82Rubidium for the diagnosis of 
CAD (p<0.05) as shown in Figure 6. Significant 
differences were found in the sensitivity and specificity 
between use of combined radiotracers (13N ammonia 
and 82Rubidium, 201Thallium and 99mTc-sestamibi) 
and use of individual radiotracers alone for the diagnosis 
of CAD (p<0.05). 
DISCUSSION 
This systematic review presents three significant 
findings which are considered to be important from a 
clinical perspective. First, the diagnostic value of SPECT 
and PET/CT in the detection of CAD is moderate when 
compared to invasive coronary angiography. Second, 
PET has higher sensitivity and specificity than SPECT or 
PET/CT for detection of CAD, indicating the increasing 
diagnostic accuracy of PET in cardiac imaging. Lastly, 
there are significant differences when different 
radiotracers are used for the diagnosis of CAD, with the 
use of combined radiotracers resulting in improved 
diagnostic value. Al Moudi et al. Biomed Imaging Interv J 2011; 7(2):e9 
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Figure 6 Pooled diagnostic value of nuclear medicine imaging with use of variable radiotracers for detection of coronary artery disease. 
 
SPECT has been used as a routine technique in 
clinical practice for myocardial perfusion imaging for 
decades [29]. Previous studies have shown that the 
diagnostic value of SPECT in cardiac imaging is variable, 
ranging from low to moderate [30]. Di Carli et al. [45] 
compared three studies using SPECT with PET, looking 
particularly at the diagnostic accuracy for detection of 
CAD. Only the sensitivity and specificity were provided 
in their study while the analysis of diagnostic accuracy 
was not identified. This analysis confirms their results to 
a greater extent, as the mean sensitivity, specificity and 
accuracy of SPECT for detection of CAD are moderate. 
This indicates that SPECT has not reached the diagnostic 
accuracy to be considered as a reliable technique for 
assessment of CAD. 
PET has been used more recently in cardiac imaging, 
and early results look promising [46]. PET offers 
potential advantages in a clinical practice over 
myocardial perfusion scintigraphy [47]. PET is able to 
assess myocardial blood flow and is superior in detecting 
multivessel disease [48]. Our analysis identifies PET as 
having the highest diagnostic value for CAD among the 
three different nuclear imaging modalities analysed. 
Husmann et al. [27] compared SPECT and PET in 
respect to diagnostic accuracy of myocardial perfusion 
imaging. Only the sensitivity and specificity were 
reported in their study, while the diagnostic accuracy was 
not available. In contrast, the sensitivity, specificity and 
accuracy of PET for detection of CAD were analysed in 
our report. This review provides a comprehensive 
analysis of the diagnostic value of these nuclear 
modalities, including sensitivity, specificity and accuracy. 
Thus, it is believed that the analysis offers additional and 
valuable diagnostic information, as compared to the 
previous reports in the literature. 
Recently, cardiac imaging has been further 
enhanced by the use of integrated PET/CT, a combined 
modality which provides the considerable benefit of 
anatomical and physiologic assessment in patients with 
CAD [37, 38]. PET/CT allows precise detection and 
localisation of CAD [39]. CT coronary angiography 
provides superior anatomical details but lacks the 
functional information of cardiac perfusion. The latest 
refinements in CT technology, including multidetector 
CT with faster gantry rotations, and dual-source devices, 
have advanced CT angiography as a promising Al Moudi et al. Biomed Imaging Interv J 2011; 7(2):e9 
 
 
alternative to conventional angiography in the diagnosis 
of CAD selected patients [49]. Recent studies have 
shown that 64-slice CTA has high sensitivity (73%- 
100%) and specificity (90%-90%) in the detection of 
CAD [50-52]. PET offers evidence of sub-clinical 
coronary atherosclerosis as it is superior in 
demonstrating metabolic activities, but its spatial 
resolution is limited when demonstrating coronary 
anatomical structures [48]. Thus, combined PET/CT 
overcomes the limitations of each individual modality 
while maximising the advantages of both PET and CT in 
cardiac imaging [45-47].  
However, the analysis of integrated PET/CT for 
detection of CAD was not as good as initially expected 
since PET/CT was shown to have moderate sensitivity, 
specificity and accuracy. This may be due to the 
selection of patients with different risk factors in the 
studies analysed. Therefore, results of this analysis 
should be interpreted with caution. PET/CT may show 
improved diagnostic accuracy in other areas, such as 
tumour imaging, but not in the diagnosis of CAD, based 
on this analysis. 
This analysis also involves a comparison of 
radiotracers used in SPECT and PET imaging which 
includes seven different types of radioisotopes, namely 
201Thallium, 
99mTc-tetrofosmin, 
99mTc-Sestamibi, a 
combination of 
201Thallium and 
99mTc-Sestamibi, 
13N 
Ammonia, 
82Rubidium, and a combination of 
13N 
Ammonia and 
82Rubidium. The comparative analysis 
indicates significant benefits of using 
13N ammonia for 
MPI to detect CAD by PET, leading to the highest 
sensitivity and accuracy. Both 
13N ammonia and 
82Rubidium have significantly high specificity in MPI by 
PET. PET imaging with use of 
13N ammonia, 
82Rubidium, 
and a combination of 
13N ammonia and 
82Rubidium for 
diagnosis of CAD, has been found to result in significant 
differences in sensitivity, specificity and accuracy than 
those using 
201Thallium, 99mTc-sestamibi, and a 
combination of 
201Thallium and 
99mTc-sestamibi by 
SPECT imaging. This is consistent with results reported 
by other studies. Go and colleagues [29] compared PET 
and SPECT in 202 patients. Their results showed there 
was no significant difference between PET imaging with 
use of 
82Rubidium and SPECT imaging with 
201Thallium. 
Tamaki and colleagues [30] compared 
13N ammonia PET 
with 
201Thallium SPECT and reported similar findings. 
Hence, this analysis confirms that 
13N ammonia PET and 
201Thallium SPECT provide high diagnostic value for 
detection of CAD. 
In addition, the analysis of individual coronary 
arteries demonstrates the superiority of PET over the 
other two modalities, but a significant difference in 
diagnostic value was only found between PET and 
SPECT, PET/CT in LAD. PET/CT was found to be 
significantly higher than PET in the assessment of RCA 
in terms of diagnostic accuracy. However, only a few 
studies presented the analysis of individual coronary 
arteries, thus a robust conclusion cannot be drawn based 
on the current analyses. 
There were some limitations identified in this study 
which need to be addressed. First, most of the studies did 
not provide detailed numbers of true positive, true 
negative cases, thus this prevented the authors from 
performing an accurate analysis of the diagnostic value 
of these modalities. Second, studies currently under 
review or submitted for publication were not included, 
although the authors did try to cover as many articles as 
possible in the search. Third, diagnostic value reported in 
each study was dependent on the radiotracers used, thus 
results should be interpreted with caution. Fourth, there 
exists variability among readers to interpret the 
angiographic images in terms of the degree of stenosis, 
for example, 50% or more stenosis [53]. Last, this 
analysis was restricted to English language literature, 
which could introduce biased opinion to the results. 
PET/CT has more potential advantages because it 
integrated two modalities but not many studies were 
found.  
CONCLUSION 
This analysis shows that PET has higher sensitivity, 
specificity and accuracy for detection of CAD than 
SPECT and PET/CT. PET can be used as a reliable, less 
invasive modality for functional analysis of patients 
suspected of CAD. Further studies comprising a large 
sample size are needed to verify these results.  
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